News
Yet greater awareness of sleep deprivation’s consequences hasn’t translated into a better-rested populace. Data from the CDC ...
Dr. Roach shares tips for good sleep hygiene including consistent sleep patterns, regular exercise, and avoiding troublesome ...
Noninvasive brain stimulation techniques, including transcranial direct current stimulation, are effective nonpharmacologic treatments for insomnia.
Hong Kong-listed, Nanjing, Jiangsu province-based Simcere Pharmaceutical Group Ltd announced on Monday that Quviviq, an anti-insomnia drug developed in collaboration with the Swiss company, Idorsia, ...
Hong Kong-listed, Nanjing, Jiangsu province-based Simcere Pharmaceutical Group Ltd announced on Monday that Quviviq, an anti-insomnia drug developed in collaboration with the Swiss company ...
The FDA’s traditional last-minute flurry of approvals as the year heads to a close included Eisai’s Dayvigo, a new treatment for insomnia that is the first direct competition to Merck & Co’s ...
Waking up at 3 a.m. every night and struggling to fall back asleep? You’re not alone. From stress and insomnia to ageing and ...
Swiss biotech Idorsia has claimed FDA approval for its first product – insomnia treatment Quviviq – setting up a market challenge to class rivals from Merck & Co and Eisai. The US regulator ...
Insomnia is the most common sleep disorder. Learn the latest that scientists have to say about causes and treatments.
Ramelteon, as the first approved melatonergic drug for treatment of insomnia, seems to be safe for short-term treatment. A major question for future scientific investigation is whether ramelteon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results